Wednesday, December 08, 2021

NEWS

Cuban Alzheimer drug makes headlines in the Dominican Republic

Cuban Alzheimer drug makes headlines in the Dominican Republic

Santo Domingo, Oct 22 (Prensa Latina) Dominican media outlets on Friday reported a new Cuban breakthrough, the production of the drug called Epo, an innovative product against Alzheimer's disease.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

On Thursday, media reported that Cuba’s Center for State Control of Drugs, Equipment and Medical Devices (CECMED) is assessing the drug.

The newspapers Hoy, Diario Digital, Portada Nacional, Diario Pais RD and the digital daily Al Momento, spread the news, according to which Cuban scientists proved the safety of this product after long years of pharmaceutical, toxicological studies, of its effectiveness in animals and diseases, and the clinical trial was carried out from 2017 to 2020.

Prensa Latina reported that this project, materialized by the Center of Molecular Immunology, the Center for Research and Development of Medicines and other Cuban institutions, consisted in the develoment of a novel formulation of recombinant human erythropoietin, with similar characteristics to that produced by the brain.

According to medical literature, Alzheimer is a progressive mental disease characterized by a degeneration of brain nerve cells and a reduction of brain mass, and its basic manifestations are memory loss, time and space disorientation and intellectual and personal deterioration.

pgh/aph/mgt/ema

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.